1 Introduction
1.1 What Is This Report About?
1.2 Interventional Cardiology Market Segmentation
1.3 Definitions of Markets Covered in the Report
2 Interventional Cardiology Market, Canada
2.1 Interventional Cardiology Market, Canada, Revenue ($m), 2024-2036
2.1.1 Coronary Stents Market, Canada, Revenue ($m), by Segment, 2024-2036
2.1.2 Intravascular Ultrasound Systems (IVUS) Market, Canada, Revenue ($m), by Segment, 2024-2036
2.1.3 PTCA Balloon Catheters Market, Canada, Revenue ($m), by Segment, 2024-2036
2.1.4 Structural Heart Occlusion Devices Market, Canada, Revenue ($m), by Segment, 2024-2036
2.1.5 Transcatheter Accessories Market, Canada, Revenue ($m), by Segment, 2024-2036
2.2 Interventional Cardiology Market, Canada, Volume (Units), 2024-2036
2.2.1 Coronary Stents Market, Canada, Volume (Units), by Segment, 2024-2036
2.2.2 Intravascular Ultrasound Systems (IVUS) Market, Canada, Volume (Units), by Segment, 2024-2036
2.2.3 PTCA Balloon Catheters Market, Canada, Volume (Units), by Segment, 2024-2036
2.2.4 Structural Heart Occlusion Devices Market, Canada, Volume (Units), by Segment, 2024-2036
2.2.5 Transcatheter Accessories Market, Canada, Volume (Units), by Segment, 2024-2036
2.3 Interventional Cardiology Market, Canada, Average Price ($), 2024-2036
2.4 Interventional Cardiology Market, Canada, Company Share by Revenue ($m), 2025
3 Interventional Cardiology Market Pipeline Products
3.1 Interventional Cardiology Market Pipeline Products
3.2 Interventional Cardiology - Pipeline Products by Stage of Development
3.3 Interventional Cardiology - Pipeline Products by Segment
3.4 Interventional Cardiology - Pipeline Products by Territory
3.5 Interventional Cardiology - Pipeline Products by Regulatory Path
3.6 Interventional Cardiology - Pipeline Products by Estimated Approval Date
4 Overview of Key Companies in Canada, Interventional Cardiology Market
4.1 Abbott Laboratories
4.1.1 Company Overview
4.2 Boston Scientific Corp
4.2.1 Company Overview
4.3 Medtronic Plc
4.3.1 Company Overview
4.4 Koninklijke Philips NV
4.4.1 Company Overview
4.5 Terumo Corp
4.5.1 Company Overview
4.6 Teleflex Inc
4.6.1 Company Overview
4.7 B. Braun Melsungen AG
4.7.1 Company Overview
4.8 W. L. Gore & Associates Inc
4.8.1 Company Overview
4.9 Asahi Intecc Co Ltd
4.9.1 Company Overview
4.10 Biotronik SE & Co KG
4.10.1 Company Overview
5 Recent Developments
5.1 Corporate Communications
5.1.1 Nov 03, 2025: Conavi Expands Leadership Team to Support U.S. Commercialization
5.1.2 Oct 29, 2025: Conavi Medical Enters Agreement with Ontario for Life Sciences Scale-Up Fund
5.1.3 Oct 29, 2025: Sparrow BioAcoustics Secures $10 Million for U.S. Deployment of Smartphone-Based Cardiac AI
5.1.4 Oct 28, 2025: Tanenbaum Institute for Science in Sport and Saint-Étienne University Hospital Collaborate on Sport and Health Research
5.1.5 Oct 28, 2025: Antegrade Medical Closes $7.3M Seed Financing
5.2 Government and Public Interest
5.2.1 Oct 14, 2025: AGFA HealthCare Powers Enterprise Imaging Modernization Across North America
5.2.2 Oct 13, 2025: Artivion Presents Late-Breaking Data from AMDS PERSEVERE and AMDS PROTECT Trials at EACTS Annual Meeting
5.3 Other Significant Developments
5.3.1 Oct 29, 2025: Conavi Medical Enters Agreement with Ontario for Life Sciences Scale-Up Fund
5.3.2 Oct 29, 2025: Sparrow BioAcoustics Secures $10 Million for U.S. Deployment of Smartphone-Based Cardiac AI
5.3.3 Oct 28, 2025: Tanenbaum Institute for Science in Sport and Saint-Étienne University Hospital Collaborate on Sport and Health Research
5.3.4 Oct 13, 2025: Artivion Presents Late-Breaking Data from AMDS PERSEVERE and AMDS PROTECT Trials at EACTS Annual Meeting
5.3.5 Oct 10, 2025: Royal Columbian Hospital Redevelopment October Project Update
5.3.6 Sep 22, 2025: Emergent BioSolutions Secures $29 Million in Product Orders from International Government Partner
5.4 Product News
5.4.1 Nov 12, 2025: VitAA Medical Receives FDA Clearance for AiORTA Plan in Aortic Care
5.4.2 Nov 03, 2025: Conavi Expands Leadership Team to Support U.S. Commercialization
5.4.3 Oct 29, 2025: Conavi Medical Enters Agreement with Ontario for Life Sciences Scale-Up Fund
5.4.4 Oct 28, 2025: Antegrade Medical Closes $7.3M Seed Financing
5.4.5 Oct 09, 2025: Asahi Kasei Achieves FDA Approval for ZOLL’s Zenix Monitor/Defibrillator
5.4.6 Oct 01, 2025: Adagio Medical Completes Enrollment in FULCRUM-VT Clinical Trial for Ventricular Tachycardia
5.5 Strategy And Business Planning
5.5.1 Oct 28, 2025: Tanenbaum Institute for Science in Sport and Saint-Étienne University Hospital Collaborate on Sport and Health Research
5.5.2 Sep 22, 2025: Emergent BioSolutions Secures $29 Million in Product Orders from International Government Partner
6 Appendix
6.1 Research Methodology
6.1.1 Coverage
6.1.2 Secondary Research
6.1.3 Primary Research
6.1.4 Market Modeling and Forecasting
6.1.5 Company Share Analysis
6.1.6 Benchmarking
6.2 the analyst Consulting
6.3 Contact the Publisher
6.4 Disclaimer
List of Tables
Table 1: Interventional Cardiology Market, Canada, Revenue ($m), USD Constant, 2024-2036
Table 2: Coronary Stents Market, Canada, Revenue ($m), USD Constant, 2024-2036
Table 3: Intravascular Ultrasound Systems (IVUS) Market, Canada, Revenue ($m), USD Constant, 2024-2036
Table 4: PTCA Balloon Catheters Market, Canada, Revenue ($m), USD Constant, 2024-2036
Table 5: Structural Heart Occlusion Devices Market, Canada, Revenue ($m), USD Constant, 2024-2036
Table 6: Transcatheter Accessories Market, Canada, Revenue ($m), USD Constant, 2024-2036
Table 7: Interventional Cardiology Market, Canada, Volume (Units), 2024-2036
Table 8: Coronary Stents Market, Canada, Volume (Units), 2024-2036
Table 9: Intravascular Ultrasound Systems (IVUS) Market, Canada, Volume (Units), 2024-2036
Table 10: PTCA Balloon Catheters Market, Canada, Volume (Units), 2024-2036
Table 11: Structural Heart Occlusion Devices Market, Canada, Volume (Units), 2024-2036
Table 12: Transcatheter Accessories Market, Canada, Volume (Units), 2024-2036
Table 13: Interventional Cardiology Market, Canada, Average Price ($), 2024-2036
Table 14: Interventional Cardiology Market, Canada, Company Share by Revenue ($m), USD Constant, 2025
Table 15: Interventional Cardiology Market Pipeline Products
Table 16: Interventional Cardiology - Pipeline Products by Stage of Development
Table 17: Interventional Cardiology Companies - Pipeline Products by Stage of Development
Table 18: Interventional Cardiology - Pipeline Products by Segment
Table 19: Interventional Cardiology - Pipeline Products by Territory
Table 20: Interventional Cardiology - Pipeline Products by Regulatory Path
Table 21: Interventional Cardiology - Pipeline Products by Estimated Approval Date
Table 22: Total Number of Primary Research Participants, Cardiovascular devices Market, by Country
List of Figures
Figure 1: Interventional Cardiology Market, Canada, Revenue ($m), USD Constant, 2024-2036
Figure 2: Coronary Stents Market, Canada, Revenue ($m), USD Constant, 2024-2036
Figure 3: Intravascular Ultrasound Systems (IVUS) Market, Canada, Revenue ($m), USD Constant, 2024-2036
Figure 4: PTCA Balloon Catheters Market, Canada, Revenue ($m), USD Constant, 2024-2036
Figure 5: Structural Heart Occlusion Devices Market, Canada, Revenue ($m), USD Constant, 2024-2036
Figure 6: Transcatheter Accessories Market, Canada, Revenue ($m), USD Constant, 2024-2036
Figure 7: Interventional Cardiology Market, Canada, Volume (Units), 2024-2036
Figure 8: Coronary Stents Market, Canada, Volume (Units), 2024-2036
Figure 9: Intravascular Ultrasound Systems (IVUS) Market, Canada, Volume (Units), 2024-2036
Figure 10: PTCA Balloon Catheters Market, Canada, Volume (Units), 2024-2036
Figure 11: Structural Heart Occlusion Devices Market, Canada, Volume (Units), 2024-2036
Figure 12: Transcatheter Accessories Market, Canada, Volume (Units), 2024-2036
Figure 13: Interventional Cardiology Market, Canada, Company Share (%), 2025
Figure 14: Interventional Cardiology - Pipeline Products by Stage of Development
Figure 15: Interventional Cardiology - Pipeline Products by Segment
Figure 16: Interventional Cardiology - Pipeline Products by Territory
Figure 17: Interventional Cardiology - Pipeline Products by Regulatory Path
Figure 18: Interventional Cardiology - Pipeline Products by Estimated Approval Date
